Synergistic delivery of FSTL1 and CHIR99021 in 3D bioprinted patches promotes adult mammalian heart repair

Recent advances in tissue engineering have positioned cardiac patch devices as a promising strategy to restore heart function and structure following myocardial infarction (MI). However, many existing patches are limited by the absence of vascular networks and insufficient biomolecular signals to effectively promote cardiomyocyte (CM) regeneration. In this study, we address these limitations by incorporating follistatin-like 1 (FSTL1) and CHIR99021 (CHIR) into a 3D bioprinted vascularized cardiac patch. The pro-proliferative effects of FSTL1 and CHIR on human induced pluripotent stem cell (hiPSC)-derived CMs were validated in vitro using 2D cultures, 3D hydrogel casts, and 3D bioprinted constructs. The synergistic impact of FSTL1 and CHIR was further evaluated in a rat model of acute MI. Treatment with the CHIR+FSTL1-loaded cardiac patch led to significant improvement in cardiac function and reduced fibrosis. Enhanced angiogenesis and increased CM proliferation were also observed following patch treatment. By integrating 3D bioprinting with targeted regenerative cues, this engineered cardiac patch presents strong therapeutic potential for myocardial repair.

Authors

Institutions

Publication Details

Journal
iScience
Published
2026-11-16
DOI
https://doi.org/10.1016/j.isci.2026.118225
Primary Topic
Tissue Engineering and Regenerative Medicine
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synergistic delivery of FSTL1 and CHIR99021 in 3D bioprinted patches promotes adult mammalian heart repair

Holly D. Bauser‐Heaton, Linqi Jin, Mehdi Salar Amoli, Boeun Hwang et al.
3 links
iScience
Tissue Engineering and Regenerative Medicine
article

Synergistic delivery of FSTL1 and CHIR99021 in 3D bioprinted patches promotes adult mammalian heart repair

Holly D. Bauser‐Heaton, Linqi Jin, Mehdi Salar Amoli, Boeun Hwang, Ming Shen, Vahid Serpooshan, Lauren Korsnick, Yamini Singh, Amritaa Basu
article en

Abstract

Recent advances in tissue engineering have positioned cardiac patch devices as a promising strategy to restore heart function and structure following myocardial infarction (MI). However, many existing patches are limited by the absence of vascular networks and insufficient biomolecular signals to effectively promote cardiomyocyte (CM) regeneration. In this study, we address these limitations by incorporating follistatin-like 1 (FSTL1) and CHIR99021 (CHIR) into a 3D bioprinted vascularized cardiac patch. The pro-proliferative effects of FSTL1 and CHIR on human induced pluripotent stem cell (hiPSC)-derived CMs were validated in vitro using 2D cultures, 3D hydrogel casts, and 3D bioprinted constructs. The synergistic impact of FSTL1 and CHIR was further evaluated in a rat model of acute MI. Treatment with the CHIR+FSTL1-loaded cardiac patch led to significant improvement in cardiac function and reduced fibrosis. Enhanced angiogenesis and increased CM proliferation were also observed following patch treatment. By integrating 3D bioprinting with targeted regenerative cues, this engineered cardiac patch presents strong therapeutic potential for myocardial repair.

iScienceVol. 29(12)
Georgia Institute of Technology (US), Emory University (US), The Wallace H. Coulter Department of Biomedical Engineering (US)
Foundation for the National Institutes of Health, Directorate for Engineering
Good health and well-being
Tissue Engineering and Regenerative Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon